Drugs / rhSOD
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00264186 | Jun 2005 → ? | — | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rhSOD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00264186 ↗ |
| Known as | Recombinant human superoxide dismutase | “Recombinant human superoxide dismutase (rhSOD) has shown potent antioxidant properties” NCT00264186 ↗ |
| Modality | Protein / enzyme biologic | “Recombinant human superoxide dismutase (rhSOD)” NCT00264186 ↗ |